{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:24:55Z","timestamp":1784291095808,"version":"3.55.0"},"reference-count":140,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.survophthal.2025.08.016","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T15:51:03Z","timestamp":1757001063000},"page":"100-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Predicting treatment response in retinal vein occlusions using baseline optical coherence tomography biomarkers: A systematic review"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4714-738X","authenticated-orcid":false,"given":"Amin","family":"Hatamnejad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keean","family":"Nanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Grad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"El-Sayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Mihalache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Gemae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia K.","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sarraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SrinVas R.","family":"Sadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien Yin","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dena","family":"Zeraatkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhiu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunir J.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion R.","family":"Munk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Borrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Steel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobha","family":"Sivaprasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles C.","family":"Wykoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9988-4146","authenticated-orcid":false,"given":"Varun","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.survophthal.2025.08.016_bib1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/2474126420943418","article-title":"Longitudinal assessment of ellipsoid zone mapping parameters in retinal venous occlusive disease with associated macular edema","volume":"5","author":"Abraham","year":"2021","journal-title":"J Vitreoretina Dis"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.016_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00417-009-1167-6","article-title":"Predictive factors for changes in macular edema in intravitreal bevacizumab therapy of retinal vein occlusion","volume":"248","author":"Ach","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2025.08.016_bib3","first-page":"1534","article-title":"Comparison of one and three initial monthly intravitreal ranibizumab injection in patients with macular edema secondary to branch retinal vein occlusion","volume":"11","author":"Alper Halil Bayat","year":"2018","journal-title":"qwer"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.016_bib4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40942-021-00306-8","article-title":"The impact of central foveal thickness and integrity of the outer retinal layers in the visual outcome of uveitic macular edema","volume":"7","author":"Alvarez-Guzman","year":"2021","journal-title":"Int J Retin Vitr"},{"key":"10.1016\/j.survophthal.2025.08.016_bib5","unstructured":"Appropriate Interpretation of OCT Imaging [Internet]. PentaVision. [cited 2024 Oct 15]. Available from: https:\/\/retinalphysician.com\/issues\/2015\/may\/appropriate-interpretation-of-oct-imaging\/."},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.016_bib6","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s40123-023-00734-9","article-title":"Foveal eversion is associated with high persistence of macular edema and visual acuity deterioration in retinal vein occlusion","volume":"12","author":"Arrigo","year":"2023","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.survophthal.2025.08.016_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ajo.2023.07.028","article-title":"OCT grading system of macular infarction predicts vision in participants with central retinal or hemiretinal vein occlusion: a secondary analysis of SCORE2","volume":"256","author":"Au","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.08.016_bib8","series-title":"High Resolution Imaging in Microscopy and Ophthalmology: New Frontiers in Biomedical Optics","first-page":"59","article-title":"Optical coherence tomography (OCT): principle and technical realization","author":"Aumann","year":"2019"},{"issue":"7","key":"10.1016\/j.survophthal.2025.08.016_bib9","first-page":"3333","article-title":"Spectral-domain OCT predictors of successful treatment discontinuation in patients with retinal vein occlusion and macular edema","volume":"63","author":"Avaylon","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.016_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/jamaophthalmol.2018.4484","article-title":"Association of disorganization of retinal inner layers with visual acuity response to Anti\u2013Vascular endothelial growth factor therapy for macular edema secondary to retinal vein occlusion","volume":"137","author":"Babiuch","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2025.08.016_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jcjo.2023.08.005","article-title":"Treatment discontinuation patterns of anti-VEGF in retinal vein occlusion","volume":"59","author":"Basilious","year":"2024","journal-title":"Can J Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2025.08.016_bib12","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1097\/IAE.0000000000001429","article-title":"Outer retinal layer changes after dexamethasone implant for central retinal vein occlusion","volume":"37","author":"Battaglia Parodi","year":"2017","journal-title":"RETINA"},{"issue":"3","key":"10.1016\/j.survophthal.2025.08.016_bib13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/IAE.0000000000001207","article-title":"Early CRT monitoring using time-domain optical coherence tomography does not add to visual acuity for predicting visual loss in patients with central retinal vein occlusion treated with intravitreal ranibizumab: a secondary analysis of trial data","volume":"37","author":"Bell","year":"2017","journal-title":"RETINA"},{"issue":"11","key":"10.1016\/j.survophthal.2025.08.016_bib14","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.oret.2018.04.019","article-title":"Association of disorganization of retinal inner layers with ischemic index and visual acuity in central retinal vein occlusion","volume":"2","author":"Berry","year":"2018","journal-title":"Ophthalmol Retin"},{"issue":"5","key":"10.1016\/j.survophthal.2025.08.016_bib15","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.ophtha.2012.11.011","article-title":"Predictive value in retinal vein occlusions of early versus late or incomplete ranibizumab response defined by optical coherence tomography","volume":"120","author":"Bhisitkul","year":"2013","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.016_bib16","first-page":"605","article-title":"Evaluation of hyperreflective foci as a prognostic factor of visual outcome in retinal vein occlusion","volume":"10","author":"Bin Mo","year":"2017","journal-title":"qwer"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.016_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12886-018-0701-x","article-title":"Pre-treatment clinical features in central retinal vein occlusion that predict visual outcome following intravitreal ranibizumab","volume":"18","author":"Brogan","year":"2018","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.016_bib18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/bjophthalmol-2017-311805","article-title":"Long-term visual outcome and its predictors in macular oedema secondary to retinal vein occlusion treated with dexamethasone implant","volume":"103","author":"Busch","year":"2019","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.08.016_bib19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/IAE.0b013e318154b9d1","article-title":"Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation","volume":"28","author":"Cakir","year":"2008","journal-title":"RETINA"},{"issue":"9","key":"10.1016\/j.survophthal.2025.08.016_bib20","doi-asserted-by":"crossref","first-page":"OCT242","DOI":"10.1167\/iovs.15-18819","article-title":"Optical coherence tomography angiography in central retinal vein occlusion: correlation between the foveal avascular zone and visual acuity","volume":"57","author":"Casselholmde Salles","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.016_bib21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12886-022-02415-w","article-title":"Optical coherence tomography biomarkers in patients with macular edema secondary to retinal vein occlusion treated with dexamethasone implant","volume":"22","author":"Castro-Navarro","year":"2022","journal-title":"BMC Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2025.08.016_bib22","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3109\/02713683.2010.496540","article-title":"A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion","volume":"35","author":"Ceki\u00e7","year":"2010","journal-title":"Curr Eye Res"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.016_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.oret.2018.07.008","article-title":"Disorganization of retinal inner layers and ellipsoid zone disruption predict visual outcomes in central retinal vein occlusion","volume":"3","author":"Chan","year":"2019","journal-title":"Ophthalmol Retin"},{"key":"10.1016\/j.survophthal.2025.08.016_bib24","unstructured":"Chapter 12: Synthesizing and presenting findings using other methods [Internet]. [cited 2024 Jul 18]. Available from: \u3008https:\/\/training.cochrane.org\/handbook\/current\/chapter-12\u3009."},{"issue":"12","key":"10.1016\/j.survophthal.2025.08.016_bib25","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.oret.2020.05.018","article-title":"Fluctuations in macular thickness in patients with retinal vein occlusion treated with Anti\u2013Vascular endothelial growth factor agents","volume":"4","author":"Chen","year":"2020","journal-title":"Ophthalmol Retin"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.016_bib26","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00417-020-04983-3","article-title":"Choroidal thickening in retinal vein occlusion patients with serous retinal detachment","volume":"259","author":"Chen","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.016_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/humupd\/dmh058","article-title":"Balancing the strengths of systematic and narrative reviews","volume":"11","author":"Collins","year":"2005","journal-title":"Hum Reprod Update"},{"issue":"15","key":"10.1016\/j.survophthal.2025.08.016_bib28","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.3390\/jcm13154533","article-title":"Evaluation of anatomical and tomographic biomarkers as predictive visual acuity factors in eyes with retinal vein occlusion treated with dexamethasone implant","volume":"13","author":"Covello","year":"2024","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.survophthal.2025.08.016_bib29","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.5301\/ejo.5000162","article-title":"Visual acuity outcome and predictive factors after bevacizumab for central retinal vein occlusion","volume":"22","author":"Daien","year":"2012","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.016_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcjo.2023.07.004","article-title":"Outcomes of anti-VEGF treatment for macular edema secondary to central retinal vein occlusion in patients with poor baseline visual acuity","volume":"59","author":"Demir","year":"2024","journal-title":"Can J Ophthalmol"},{"issue":"15","key":"10.1016\/j.survophthal.2025.08.016_bib31","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.2147\/IJGM.S373015","article-title":"Effect of conbercept treatment on macular edema and microvascular structure in eyes with retinal vein occlusions","volume":"15","author":"Ding","year":"2022","journal-title":"IJGM"},{"issue":"3","key":"10.1016\/j.survophthal.2025.08.016_bib32","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/IAE.0000000000002872","article-title":"Central retinal vein occlusion in young patients: clinical characteristics and prognostic factors","volume":"41","author":"Eah","year":"2021","journal-title":"RETINA"},{"key":"10.1016\/j.survophthal.2025.08.016_bib33","unstructured":"Elias, Reichel, Joseph Ho, Jay S. Duker. OCT Units: Which One Is Right for Me? [Internet]. [cited 2024 Oct 15]. Available from: \u3008https:\/\/www.reviewofophthalmology.com\/article\/oct-units-which-one-is-right-for-me\u3009."},{"key":"10.1016\/j.survophthal.2025.08.016_bib34","doi-asserted-by":"crossref","unstructured":"Engels B. XNomial: Exact Goodness-of-Fit Test for Multinomial Data with Fixed Probabilities [Internet]. 2015 [cited 2024 Jul 18]. Available from: https:\/\/cran.r-project.org\/web\/packages\/XNomial\/index.html.","DOI":"10.32614\/CRAN.package.XNomial"},{"issue":"3","key":"10.1016\/j.survophthal.2025.08.016_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1167\/tvst.10.3.31","article-title":"Ellipsoid zone defects in retinal vein occlusion correlates with visual acuity prognosis: SCORE2 report 14","volume":"10","author":"Etheridge","year":"2021","journal-title":"Transl Vis Sci Technol"},{"issue":"5","key":"10.1016\/j.survophthal.2025.08.016_bib36","doi-asserted-by":"crossref","first-page":"761","DOI":"10.5301\/ejo.5000448","article-title":"Intravitreal bevacizumab combined with grid photocoagulation in recurrent macular edema secondary to retinal vein occlusion","volume":"24","author":"Farese","year":"2014","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.08.016_bib37","doi-asserted-by":"crossref","first-page":"324","DOI":"10.18502\/jovr.v19i3.13531","article-title":"Predictive factors for functional and anatomical outcomes after Anti-VEGF treatment for macular edema in patients with branch retinal vein occlusion","volume":"19","author":"Ferreira","year":"2024","journal-title":"jovr"},{"issue":"9","key":"10.1016\/j.survophthal.2025.08.016_bib38","first-page":"3596","article-title":"Anatomic feature dynamics and perfusion density following aflibercept therapy in retinal vascular disease in the PERMEATE study","volume":"59","author":"Figueiredo","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.016_bib39","doi-asserted-by":"crossref","first-page":"P288","DOI":"10.1016\/j.ophtha.2019.09.029","article-title":"Retinal vein occlusions preferred practice Pattern\u00ae","volume":"127","author":"Flaxel","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2025.08.016_bib40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jclinepi.2019.12.023","article-title":"GRADE guidelines 28: use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks","volume":"121","author":"Foroutan","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.survophthal.2025.08.016_bib41","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2147\/OPTH.S110793","article-title":"Optical coherence tomography parameters predictive of visual outcome after anti-VEGF therapy for retinal vein occlusion","volume":"10","author":"Fujihara-Mino","year":"2016","journal-title":"OPTH"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.016_bib42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00417-012-2023-7","article-title":"Ranibizumab for serous macular detachment in branch retinal vein occlusions","volume":"251","author":"Gallego-Pinazo","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.08.016_bib43","unstructured":"GRADE handbook [Internet]. [cited 2024 Jul 18]. Available from: \u3008https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html\u3009."},{"issue":"6","key":"10.1016\/j.survophthal.2025.08.016_bib44","doi-asserted-by":"crossref","DOI":"10.1111\/eci.12931","article-title":"Time to challenge the spurious hierarchy of systematic over narrative reviews?","volume":"48","author":"Greenhalgh","year":"2018","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.016_bib45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000487489","article-title":"Spectral-Domain optical coherence Tomography-Driven Treat-and-Extend and pro re nata regimen in patients with macular oedema due to retinal vein occlusion: 24-Month evaluation and outcome predictors","volume":"60","author":"Guichard","year":"2018","journal-title":"Ophthalmic Res"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.016_bib46","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.survophthal.2025.08.016_bib47","series-title":"Wiley Frontlist Obook Health Science, Wiley, Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2019"},{"issue":"11","key":"10.1016\/j.survophthal.2025.08.016_bib48","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00417-010-1419-5","article-title":"OCT patterns of macular edema and response to bevacizumab therapy in retinal vein occlusion","volume":"248","author":"Hoeh","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2025.08.016_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258728","article-title":"Role of the choroidal vascularity index in branch retinal vein occlusion (BRVO) with macular edema","volume":"16","author":"Hwang","year":"2021","journal-title":"PLOS ONE"},{"key":"10.1016\/j.survophthal.2025.08.016_bib50","doi-asserted-by":"crossref","first-page":"60","DOI":"10.5935\/0004-2749.20230019","article-title":"Afibercept treatment for macular edema with and without serous retinal detachment due to branch retinal vein occlusion","volume":"86","author":"Irgat","year":"2022","journal-title":"Arq Bras Oftalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.08.016_bib51","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00417-016-3471-2","article-title":"Predictive factors for functional improvement following intravitreal bevacizumab injections after central retinal vein occlusion","volume":"255","author":"Januschowski","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"13","key":"10.1016\/j.survophthal.2025.08.016_bib52","first-page":"3867","article-title":"Spectral-Domain optical coherence tomographic finding of macular edema associated with central retinal vein occlusion as a predictor of response to bevacizumab","volume":"55","author":"Ji","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.016_bib53","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12886-024-03298-9","article-title":"Characteristics of macular edema associated with retinal vein occlusion showing poor anatomic response to three loading anti-vascular endothelial growth factor injections: an optical coherence tomography analysis","volume":"24","author":"Johari","year":"2024","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.08.016_bib54","unstructured":"Journal of Retina-Vitreous [Internet]. [cited 2024 Jul 19]. Available from: \u3008https:\/\/retinavitreus.dergisi.org\/abstract.php?lang=en&id=1354\u3009."},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.016_bib55","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00417-012-2067-8","article-title":"Spectral-domain optical coherence tomography (SD-OCT) patterns and response to intravitreal bevacizumab therapy in macular edema associated with branch retinal vein occlusion","volume":"251","author":"Kang","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2025.08.016_bib56","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00417-014-2595-5","article-title":"Correlation between optical coherence tomographic hyperreflective foci and visual outcomes after intravitreal bevacizumab for macular edema in branch retinal vein occlusion","volume":"252","author":"Kang","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2025.08.016_bib57","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4274\/tjo.75317","article-title":"N. The efficacy and safety of intravitreal dexamethasone implant for the treatment of macular edema related to retinal vein occlusion: Real-life data and prognostic factors in a turkish population","volume":"47","author":"Kanra","year":"2017","journal-title":"Turk J Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2025.08.016_bib58","first-page":"4084","article-title":"The relationship between structural change of distinct retinal layers and visual prognosis in patients with macular edema secondary to branchial retinal vein occlusion","volume":"60","author":"Katsuyama","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.survophthal.2025.08.016_bib59","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s00417-020-05018-7","article-title":"Association between early and late response in eyes with central or hemiretinal vein occlusion treated with anti-VEGF agents","volume":"259","author":"Khurana","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.016_bib60","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3346\/jkms.2015.30.4.475","article-title":"Baseline predictors of visual acuity and retinal thickness in patients with retinal vein occlusion","volume":"30","author":"Kim","year":"2015","journal-title":"J Korean Med Sci"},{"issue":"3","key":"10.1016\/j.survophthal.2025.08.016_bib61","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000334906","article-title":"Intravitreal ranibizumab for macular edema secondary to retinal vein occlusion","volume":"227","author":"Kim","year":"2011","journal-title":"Ophthalmologica"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.016_bib62","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10792-024-03272-w","article-title":"Association between time to treatment and outcome in branch retinal vein occlusion","volume":"44","author":"Kitano","year":"2024","journal-title":"Int Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2025.08.016_bib63","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/IAE.0000000000000054","article-title":"Optical coherence tomography predicts visual outcome in acute central retinal vein occlusion","volume":"34","author":"Ko","year":"2014","journal-title":"RETINA"},{"key":"10.1016\/j.survophthal.2025.08.016_bib64","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ajo.2021.01.027","article-title":"Efficacy and safety of intravitreal aflibercept Treat-and-Extend for macular edema in central retinal vein occlusion: the CENTERA study","volume":"227","author":"Korobelnik","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"S256","key":"10.1016\/j.survophthal.2025.08.016_bib65","article-title":"Relationship between visual outcomes and initial optical coherence tomographic findings in macular edema secondary to branch retinal vein occlusion after bevacizumab treatment","volume":"94","author":"Kwon","year":"2016","journal-title":"Acta Ophthalmol [Internet]"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.016_bib66","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3341\/kjo.2017.31.2.108","article-title":"Dexamethasone intravitreal implant rescue treatment for bevacizumab refractory macular edema secondary to branch retinal vein occlusion","volume":"31","author":"Lee","year":"2017","journal-title":"Korean J Ophthalmol"},{"issue":"15","key":"10.1016\/j.survophthal.2025.08.016_bib67","first-page":"1129","article-title":"Retrospective study of Anti-Vascular endothelial growth factor therapy in the treatment of branch retinal vein occlusion and predictive factors for visual outcome","volume":"54","author":"Lei","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.016_bib68","first-page":"890","article-title":"Predicting the visual acuity for retinal vein occlusion after ranibizumab therapy with an original ranking for macular microstructure","volume":"15","author":"Liu","year":"2018","journal-title":"Exp Ther Med"},{"issue":"7","key":"10.1016\/j.survophthal.2025.08.016_bib69","first-page":"5802","article-title":"Baseline predictors of early visual acuity improvement in RVO patients treated with ranibizumab in the SHORE study","volume":"56","author":"Liu","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.016_bib70","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3928\/23258160-20210201-05","article-title":"Patterns and predictors of successful treatment discontinuation in retinal vein occlusions with macular edema in the real world","volume":"52","author":"Lo","year":"2021","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.016_bib71","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ophtha.2022.08.012","article-title":"Diabetic macular edema and diode subthreshold micropulse laser: a randomized Double-Masked noninferiority clinical trial","volume":"130","author":"Lois","year":"2023","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.016_bib72","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000364956","article-title":"Intravitreal dexamethasone implant for macular edema secondary to retinal vein occlusion: 12-month Follow-Up and prognostic factors","volume":"232","author":"Maggio","year":"2014","journal-title":"Ophthalmologica"},{"issue":"8","key":"10.1016\/j.survophthal.2025.08.016_bib73","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1167\/iovs.18-24153","article-title":"Increased inner retinal layer reflectivity in eyes with acute CRVO correlates with worse visual outcomes at 12 months","volume":"59","author":"Mehta","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.survophthal.2025.08.016_bib74","first-page":"5437","article-title":"Initial loss of interdigitation zone on OCT following CRVO May predict future visual acuity improvement","volume":"59","author":"Messenger","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2025.08.016_bib75","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ajo.2017.08.005","article-title":"Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with macular edema secondary to vein occlusion","volume":"182","author":"Mimouni","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2025.08.016_bib76","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/bjophthalmol-2020-316214","article-title":"Changes in choroidal structure following intravitreal aflibercept therapy for retinal vein occlusion","volume":"105","author":"Mitamura","year":"2021","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.016_bib77","first-page":"605","article-title":"Evaluation of hyperreflective foci as a prognostic factor of visual outcome in retinal vein occlusion","volume":"10","author":"Mo","year":"2017","journal-title":"Int. J. Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.08.016_bib78","article-title":"Real - life functional impact of baseline anatomical biomarkers in retinal edema secondary to branch vein occlusion treated with dexamethasone implant","volume":"244","author":"Monferrer-Adsuara","year":"2021","journal-title":"Ophthalmologica"},{"issue":"6","key":"10.1016\/j.survophthal.2025.08.016_bib79","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/IAE.0000000000001674","article-title":"PREDICTORS OF REFRACTORY MACULAR EDEMA AFTER BRANCH RETINAL VEIN OCCLUSION FOLLOWING INTRAVITREAL BEVACIZUMAB","volume":"38","author":"Moon","year":"2018","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.survophthal.2025.08.016_bib80","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s10384-021-00852-6","article-title":"Aniseikonia following intravitreal ranibizumab treatment for branch retinal vein occlusion","volume":"65","author":"Morikawa","year":"2021","journal-title":"Jpn J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.08.016_bib81","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/ebmed-2017-110668","article-title":"Rating the certainty in evidence in the absence of a single estimate of effect","volume":"22","author":"Murad","year":"2017","journal-title":"Evid Based Med"},{"issue":"9","key":"10.1016\/j.survophthal.2025.08.016_bib82","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1097\/IAE.0b013e31824b824c","article-title":"Disrupted foveal photoreceptors after combined cystoid spaces and retinal detachment in branch vein occlusion treated with bevacizumab","volume":"32","author":"Murakami","year":"2012","journal-title":"Retina"},{"issue":"15","key":"10.1016\/j.survophthal.2025.08.016_bib83","first-page":"2829","article-title":"Outer retinal edema as a risk factor for poor visual outcome after bevacizumab therapy for macular edema with branch retinal vein occlusion","volume":"54","author":"Muramatsu","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.survophthal.2025.08.016_bib84","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10384-013-0236-x","article-title":"Branch retinal vein occlusion-associated subretinal hemorrhage","volume":"57","author":"Muraoka","year":"2013","journal-title":"Jpn J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.08.016_bib85","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3928\/23258160-20220215-03","article-title":"The quantification and impact of persistent retinal fluid compartments on Best-Corrected visual acuity of patients with retinal vein occlusion","volume":"53","author":"Muste","year":"2022","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.016_bib86","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1080\/02713683.2016.1214968","article-title":"Comparison of dexamethasone intravitreal implant with conventional triamcinolone in patients with postoperative cystoid macular edema","volume":"42","author":"Mylonas","year":"2017","journal-title":"Curr Eye Res"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.016_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2023.100418","article-title":"Foveal thickness fluctuations in Anti-VEGF treatment for central retinal vein occlusion","volume":"4","author":"Nagasato","year":"2024","journal-title":"Ophthalmol Sci"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.016_bib88","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000490809","article-title":"Disorganization of the retinal inner layers after Anti-VEGF treatment for macular edema due to branch retinal vein occlusion","volume":"240","author":"Nakano","year":"2018","journal-title":"Ophthalmologica"},{"issue":"9","key":"10.1016\/j.survophthal.2025.08.016_bib89","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.4103\/ijo.IJO_342_18","article-title":"Baseline morphological characteristics as predictors of final visual acuity in patients with branch retinal vein occlusions: MARVEL report no. 3","volume":"66","author":"Narayanan","year":"2018","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.08.016_bib90","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2147\/OPTH.S361636","article-title":"Modified microneedle for suprachoroidal injection of triamcinolone acetonide combined with intravitreal injection of ranibizumab in branch retinal vein occlusion patients","volume":"16","author":"Nawar","year":"2022","journal-title":"OPTH"},{"issue":"5","key":"10.1016\/j.survophthal.2025.08.016_bib91","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/s41433-022-02007-4","article-title":"Retinal vein occlusion (RVO) guideline: executive summary","volume":"36","author":"Nicholson","year":"2022","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.016_bib92","article-title":"Analysis of morphologic and functional outcomes in macular edema due to central retinal vein occlusion treated with intravitreal dexamethasone implant","volume":"2018","author":"Niro","year":"2018","journal-title":"J Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2025.08.016_bib93","first-page":"2595","article-title":"Choroidal thickness changes as a predictor of visual acuity improvement in retinal vein occlusion patients","volume":"60","author":"Noh","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.016_bib94","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000486248","article-title":"Impact of early anatomical and functional responses to bevacizumab in macular edema secondary to branch retinal vein occlusion","volume":"239","author":"Noh","year":"2018","journal-title":"Ophthalmologica"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.016_bib95","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2415-12-39","article-title":"Comparison of the efficacy of intravitreal triamcinolone acetonide for cystoid macular edema with versus without serous retinal detachment in branch retinal vein occlusion: influence on macular sensitivity and morphology","volume":"12","author":"Noma","year":"2012","journal-title":"BMC Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2025.08.016_bib96","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.ophtha.2004.04.031","article-title":"Delayed absorption of macular edema accompanying serous retinal detachment after grid laser treatment in patients with branch retinal vein occlusion","volume":"111","author":"Ohashi","year":"2004","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.survophthal.2025.08.016_bib97","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1136\/bjo.2007.118497","article-title":"Association between integrity of foveal photoreceptor layer and visual acuity in branch retinal vein occlusion","volume":"91","author":"Ota","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.016_bib98","first-page":"53","article-title":"The relationship between disorganitazion of the retinal inner layers and Anti-VEGF response in branch retinal vein occlusion","volume":"29","author":"Ozsaygili","year":"2020","journal-title":"J RetinVitr"},{"key":"10.1016\/j.survophthal.2025.08.016_bib99","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"13","key":"10.1016\/j.survophthal.2025.08.016_bib100","first-page":"1820","article-title":"Dexamethasone IV for RVO: is there a reliable prognostic factor?","volume":"55","author":"Panozzo","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.survophthal.2025.08.016_bib101","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/IAE.0b013e3182a4871c","article-title":"CORRELATION OF FUNDUS AUTOFLUORESCENCE WITH FOVEAL MICROSTRUCTURES AND VISION IN BRANCH RETINAL VEIN OCCLUSION","volume":"34","author":"Park","year":"2014","journal-title":"RETINA"},{"issue":"3","key":"10.1016\/j.survophthal.2025.08.016_bib102","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000357275","article-title":"Exploring the morphological and functional retinal changes after dexamethasone intravitreal implant (Ozurdex\u00ae) in macular edema due to retinal vein occlusion","volume":"51","author":"Parravano","year":"2014","journal-title":"Ophthalmic Res"},{"issue":"7","key":"10.1016\/j.survophthal.2025.08.016_bib103","first-page":"5927","article-title":"The foveal shape is not predictive of visual acuity and treatment response in macular edema due to retinal vein occlusion","volume":"56","author":"Podkowinski","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.survophthal.2025.08.016_bib104","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/jop.2012.0140","article-title":"Clinical implications of serous retinal detachment in branch retinal vein occlusion and response after primary intravitreal bevacizumab injection","volume":"29","author":"Poon","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.016_bib105","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1755-3768.2010.01913.x","article-title":"Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes","volume":"90","author":"Puche","year":"2012","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.016_bib106","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/IAE.0b013e31829f7495","article-title":"Impact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and function","volume":"34","author":"Querques","year":"2014","journal-title":"RETINA"},{"key":"10.1016\/j.survophthal.2025.08.016_bib107","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ajo.2016.08.026","article-title":"Baseline choroidal thickness as a predictor for treatment outcomes in central retinal vein occlusion","volume":"171","author":"Rayess","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.016_bib108","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/bjophthalmol-2018-311898","article-title":"Baseline choroidal thickness as a short-term predictor of visual acuity improvement following antivascular endothelial growth factor therapy in branch retinal vein occlusion","volume":"103","author":"Rayess","year":"2019","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2025.08.016_bib109","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/IAE.0b013e3181cd4894","article-title":"Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study","volume":"30","author":"Rouvas","year":"2010","journal-title":"RETINA"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.016_bib110","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1442-9071.2009.01914.x","article-title":"Evaluation of potential visual acuity in eyes with macular oedema secondary to retinal vein occlusion","volume":"37","author":"Sakamoto","year":"2009","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.08.016_bib111","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jclinepi.2019.10.014","article-title":"GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions","volume":"119","author":"Santesso","year":"2020","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.016_bib112","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-95501-w","article-title":"Smooth borders between inner nuclear layer and outer plexiform layer predict fewer macular edema recurrences in branch retinal vein occlusion","volume":"11","author":"Sasajima","year":"2021","journal-title":"Sci Rep"},{"issue":"32","key":"10.1016\/j.survophthal.2025.08.016_bib113","doi-asserted-by":"crossref","first-page":"E901","DOI":"10.1503\/cmaj.200077","article-title":"Development of the instrument to assess the credibility of effect modification analyses (ICEMAN) in randomized controlled trials and meta-analyses","volume":"192","author":"Schandelmaier","year":"2020","journal-title":"CMAJ"},{"issue":"3","key":"10.1016\/j.survophthal.2025.08.016_bib114","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000502041","article-title":"Guidelines for the management of retinal vein occlusion by the european society of retina specialists (EURETINA)","volume":"242","author":"Schmidt-Erfurth","year":"2019","journal-title":"Ophthalmologica"},{"issue":"5","key":"10.1016\/j.survophthal.2025.08.016_bib115","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00417-021-05494-5","article-title":"SCORE2 report 17: macular thickness fluctuations in anti-VEGF-treated patients with central or hemiretinal vein occlusion","volume":"260","author":"Scott","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2025.08.016_bib116","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jamaophthalmol.2017.1141","article-title":"Baseline factors associated with 6-Month visual acuity and retinal thickness outcomes in patients with macular edema secondary to central retinal vein occlusion or hemiretinal vein occlusion: SCORE2 study report 4","volume":"135","author":"Scott","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.016_bib117","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ophtha.2010.06.034","article-title":"Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: standard care versus COrticosteroid for REtinal vein occlusion study report 10","volume":"118","author":"Scott","year":"2011","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.016_bib118","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10792-020-01604-0","article-title":"Predicting response of ischemic central retinal vein occlusion to bevacizumab injections: 1 year follow-up","volume":"41","author":"Segal","year":"2021","journal-title":"Int Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.016_bib119","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000519373","article-title":"Optical coherence tomography biomarkers predicting visual acuity change after intravitreal bevacizumab injections for macular edema secondary to branch retinal vein occlusion","volume":"245","author":"Segal","year":"2021","journal-title":"Ophthalmologica"},{"issue":"11","key":"10.1016\/j.survophthal.2025.08.016_bib120","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.oret.2021.02.008","article-title":"Predictors of visual acuity outcomes after Anti\u2013Vascular endothelial growth factor treatment for macular edema secondary to central retinal vein occlusion","volume":"5","author":"Sen","year":"2021","journal-title":"Ophthalmol Retin"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.016_bib121","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1111\/j.1755-3768.2010.02063.x","article-title":"Association between integrity of foveal photoreceptor layer and visual outcome in retinal vein occlusion","volume":"89","author":"Shin","year":"2011","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.08.016_bib122","unstructured":"Signorell A., Aho K., Alfons A., et al. DescTools: Tools for Descriptive Statistics [Internet]. 2024 [cited 2024 Jul 18]. Available from: \u3008https:\/\/cran.r-project.org\/web\/packages\/DescTools\/index.html\u3009."},{"issue":"12","key":"10.1016\/j.survophthal.2025.08.016_bib123","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.ophtha.2019.07.018","article-title":"Different factors associated with 2-Year outcomes in patients with branch versus central retinal vein occlusion treated with ranibizumab","volume":"126","author":"Sophie","year":"2019","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.survophthal.2025.08.016_bib124","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10384-020-00758-9","article-title":"Time course of changes in contrast sensitivity following intravitreal ranibizumab injection for branch retinal vein occlusion","volume":"64","author":"Sugiura","year":"2020","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.016_bib125","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1038\/s41598-021-84038-7","article-title":"Relationship between metamorphopsia and inner retinal microstructure following intravitreal ranibizumab injection for branch retinal vein occlusion","volume":"11","author":"Sugiura","year":"2021","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.survophthal.2025.08.016_bib126","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1007\/s40123-022-00588-7","article-title":"Three monthly injections versus one initial injection of ranibizumab for the treatment of macular edema secondary to branch retinal vein occlusion: 12-Month results of a prospective randomized study","volume":"11","author":"Tang","year":"2022","journal-title":"Ophthalmol Ther"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.016_bib127","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/IAE.0000000000002444","article-title":"Optical coherence tomography predictors of short-term visual acuity in eyes with macular edema secondary to retinal vein occlusion treated with intravitreal conbercept","volume":"40","author":"Tang","year":"2020","journal-title":"RETINA"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.016_bib128","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/bjophthalmol-2020-317615","article-title":"Disorganisation of retinal inner layers is associated with reduced contrast sensitivity in retinal vein occlusion","volume":"106","author":"Wang","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.08.016_bib129","unstructured":"What is GRADE? | BMJ Best Practice [Internet]. [cited 2024 Aug 5]. Available from: \u3008https:\/\/bestpractice.bmj.com\/info\/us\/toolkit\/learn-ebm\/what-is-grade\/\u3009."},{"issue":"6","key":"10.1016\/j.survophthal.2025.08.016_bib130","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1167\/iovs.10-6097","article-title":"Predictors of Short-Term visual outcome after Anti-VEGF therapy of macular edema due to central retinal vein occlusion","volume":"52","author":"Wolf-Schnurrbusch","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"15","key":"10.1016\/j.survophthal.2025.08.016_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e35406","article-title":"Relationship between retinal volume changes and the prognosis of BRVO-ME treated with ranibizumab","volume":"10","author":"Xing","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.survophthal.2025.08.016_bib132","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.839082","article-title":"Potential prognostic indicators for patients with retinal vein occlusion","volume":"9","author":"Yin","year":"2022","journal-title":"Front Med"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.016_bib133","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.oret.2019.08.009","article-title":"Spectral-Domain OCT predictors of visual outcomes after ranibizumab treatment for macular edema resulting from retinal vein occlusion","volume":"4","author":"Yiu","year":"2020","journal-title":"Ophthalmol Retin"},{"issue":"6","key":"10.1016\/j.survophthal.2025.08.016_bib134","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3928\/23258160-20190605-03","article-title":"Association of retinal inner layer disorganization with Ultra-Widefield fluorescein angiographic features and visual acuity in branch retinal vein occlusion","volume":"50","author":"Yu","year":"2019","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.016_bib135","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10384-011-0114-3","article-title":"Treatment of macular edema due to branch retinal vein occlusion with single or multiple intravitreal injections of bevacizumab","volume":"56","author":"Yunoki","year":"2012","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.016_bib136","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12886-021-02174-0","article-title":"Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with conbercept","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2025.08.016_bib137","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1089\/jop.2011.0050","article-title":"Intravitreal bevacizumab for treatment of macular edema secondary to central retinal vein occlusion: Eighteen-Month results of a prospective trial","volume":"27","author":"Zhang","year":"2011","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.survophthal.2025.08.016_bib138","doi-asserted-by":"crossref","unstructured":"Zhao R., Han F., Fu L., Tan W. Factors influencing ranibizumab efficacy and prognosis of patients with retinal vein occlusion and macular edema based on systemic inflammatory indexes and OCT parameters [Internet]. 2024 [cited 2025 Feb 27]. doi:10.22514\/jomh.2024.079.","DOI":"10.22514\/jomh.2024.079"},{"issue":"7","key":"10.1016\/j.survophthal.2025.08.016_bib139","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3109\/02713683.2014.952827","article-title":"Bevacizumab treatment for acute branch retinal vein occlusion accompanied by subretinal hemorrhage","volume":"40","author":"Zhao","year":"2015","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.survophthal.2025.08.016_bib140","unstructured":"\u848b\u6b63\u8f69\u6842\u884d\u8d85, Zheng-Xuan Jiang Y.C.G. OCT\u53c2\u6570\u4f5c\u4e3a\u96f7\u73e0\u5355\u6297\u6cbb\u7597\u89c6\u7f51\u819c\u4e2d\u592e\u9759\u8109\u963b\u585e\u7ee7\u53d1\u9ec4\u6591\u6c34\u80bf\u7597\u6548\u7684\u9884\u6d4b\u6307\u6807. \u56fd\u9645\u773c\u79d1\u6742\u5fd7. 2022 Jul 27;22(8):1339\u20131344. doi:10.3980\/j.issn.1672-5123.2022.8.19."}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625725001481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625725001481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:27:22Z","timestamp":1778945242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625725001481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":140,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0039625725001481"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2025.08.016","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting treatment response in retinal vein occlusions using baseline optical coherence tomography biomarkers: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2025.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}